Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M114,010Revenue (TTM) $M16,455Net Margin (%)32.7Altman Z-Score14.0
Enterprise Value $M114,303EPS (TTM) $2.1Operating Margin %43.4Piotroski F-Score7
P/E(ttm)20.5Beneish M-Score-2.6Pre-tax Margin (%)40.8Higher ROA y-yN
Price/Book17.410-y EBITDA Growth Rate %19.2Quick Ratio0.9Cash flow > EarningsY
Price/Sales6.85-y EBITDA Growth Rate %17.9Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow20.3y-y EBITDA Growth Rate %-1.0ROA % (ttm)42.0Higher Current Ratio y-yY
Dividend Yield %3.2PEG1.2ROE % (ttm)86.3Less Shares Outstanding y-yY
Payout Ratio %45.0Shares Outstanding M2,600ROIC % (ttm)139Gross Margin Increase y-yY

Gurus Latest Trades with NVO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVOKen Fisher 2016-06-30 Reduce-0.02%$50.91 - $57.51
($54.83)
$ 43.85-20%Reduce -1.93%10,963,094
NVORuane Cunniff 2016-06-30 Reduce$50.91 - $57.51
($54.83)
$ 43.85-20%Reduce -3.45%94,165
NVOMario Gabelli 2016-06-30 Reduce$50.91 - $57.51
($54.83)
$ 43.85-20%Reduce -0.79%6,176
NVOKen Fisher 2016-03-31 Reduce-0.03%$46.58 - $58.08
($53.57)
$ 43.85-18%Reduce -2.35%11,178,809
NVORuane Cunniff 2016-03-31 Add0.01%$46.58 - $58.08
($53.57)
$ 43.85-18%Add 19.93%97,525
NVOMario Gabelli 2016-03-31 Add$46.58 - $58.08
($53.57)
$ 43.85-18%Add 0.24%6,225
NVOKen Fisher 2015-12-31 Reduce-0.02%$52.93 - $58.77
($55.36)
$ 43.85-21%Reduce -1.76%11,447,413
NVOMario Gabelli 2015-12-31 Add$52.93 - $58.77
($55.38)
$ 43.85-21%Add 0.65%6,210
NVOKen Fisher 2015-09-30 Reduce-0.07%$52.8 - $60.23
($56.62)
$ 43.85-23%Reduce -5.23%11,652,268
NVORuane Cunniff 2015-09-30 Reduce$52.8 - $60.23
($56.62)
$ 43.85-23%Reduce -0.59%81,320
NVOMario Gabelli 2015-09-30 Reduce$52.8 - $60.23
($56.62)
$ 43.85-23%Reduce -5.73%6,170
NVOKen Fisher 2015-06-30 Reduce-0.04%$53.39 - $58.02
($56.17)
$ 43.85-22%Reduce -2.88%12,295,864
NVORuane Cunniff 2015-06-30 Reduce$53.39 - $58.02
($56.17)
$ 43.85-22%Reduce -0.30%81,800
NVOMario Gabelli 2015-06-30 Reduce$53.39 - $58.02
($56.17)
$ 43.85-22%Reduce -2.31%6,545
NVOKen Fisher 2015-03-31 Reduce-0.03%$41.9 - $54.68
($46.05)
$ 43.85-5%Reduce -2.91%12,660,235
NVORuane Cunniff 2015-03-31 Reduce$41.9 - $54.68
($46.05)
$ 43.85-5%Reduce -0.17%82,050
NVOMario Gabelli 2015-03-31 Reduce$41.9 - $54.68
($46.05)
$ 43.85-5%Reduce -0.30%6,700
NVORuane Cunniff 2014-09-30 Reduce-0.02%$43.9 - $49.03
($46)
$ 43.85-5%Reduce -52.87%75,642
NVORuane Cunniff 2014-06-30 Reduce-0.02%$42.28 - $46.52
($44.12)
$ 43.85-1%Reduce -33.85%160,492
NVORuane Cunniff 2014-03-31 Reduce-0.01%$36.722 - $48.23
($42.37)
$ 43.853%Reduce -21.98%242,630
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about NVO:

    News about NVO:

    Articles On GuruFocus.com
    Stocks With High Yield: Oracle, Cal-Maine, Infosys Jul 28 2016 
    My Favorite Health Care Stocks Jul 12 2016 
    Nintai Charitable Trust's 2nd-Quarter Results Jul 01 2016 
    High Yield, Strong Returns: Sturm Ruger, Nu Skin Enterprises Jun 23 2016 
    Stocks Mario Gabelli Has Bought for 2 Quarters Jun 20 2016 
    Jim Simons' Top Holdings Include VeriSign, Chipotle Dec 15 2015 
    Value Investing in BioPharma Nov 18 2015 
    Jim Simons' Five Most-Heavily Weighted Holdings Oct 21 2015 
    Ken Fisher Reduces Stake in Toyota, Increases Position in Anheuser-Busch Oct 20 2015 
    Jim Simons and Ken Fisher Decrease Exposure on Novo Nordisk A/S Sep 14 2015 

    More From Other Websites
    Stocks Up After 1st Presidential Debate; Why Tesla Looks Healthiest In Weeks Sep 27 2016
    Novo Nordisk A/S - Share repurchase programme Sep 26 2016
    8:28 am Novo Nordisk submits application in the US for including data from the 2 Switch trials in... Sep 25 2016
    Novo Nordisk submits application in the US for including data from the two SWITCH trials in... Sep 23 2016
    Coverage initiated on Novo Nordisk A/S by Piper Jaffray Sep 23 2016
    Novo Nordisk to supply insulin at discount to poorest nations Sep 21 2016
    Novo Nordisk A/S - Share repurchase programme Sep 19 2016
    ‘Holy Grail’ of Oral Insulin Gives Way to Other Tablets at Novo Sep 19 2016
    There's something odd about the way insulin prices change Sep 17 2016
    NovoRapid® receives positive CHMP opinion for extended use in children as young as one year old Sep 16 2016
    Novo Nordisk's diabetes drug semaglutide cuts heart risk by 26 percent Sep 16 2016
    A 93-year-old drug that can cost more than a mortgage payment tells us everything that's wrong with... Sep 15 2016
    Great Place to Work® and Fortune name Novo Nordisk as one of the country's best workplaces for... Sep 15 2016
    Victoza® lowered the progression of kidney damage in adults with type 2 diabetes at high CV risk Sep 15 2016
    A 93-year-old drug that some children can't live without tells us everything that's wrong with... Sep 15 2016
    Novo Nordisk (NVO) Presents Data on Obesity Drug Saxenda Sep 15 2016
    Saxenda® provides consistent weight loss and improvements in blood glucose control across BMI... Sep 14 2016
    Adults with type 2 diabetes treated with Xultophy® (IDegLira) were up to 4.5 times more likely to... Sep 14 2016
    Semaglutide demonstrated superior HbA1c reduction vs placebo as add-on to basal insulin alone or... Sep 13 2016
    Adults with type 2 diabetes treated with Xultophy® (IDegLira) were up to 4.5 times more likely to... Sep 13 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)